Wellnex Life (ASX:WNX) Investor Briefing - 19th December 2024

Wellnex Life (ASX:WNX): Investor Briefing with Managing Director Zack Bozinovski and Non-Executive Chairman George Tambassis

Reach Markets sat with Managing Director Zack Bozinovski and Non-Executive Chairman George Tambassis to provide a final update of 2024, which proved to be a transformational year for Wellnex.

During the session, Zack and George discussed:

Their performance and achievements across 2024.
Major progress with their international partnerships.
The high-profile industry veterans joining the board.
An outlook on 2025 as they progress towards a listing on the London Stock Exchange.

Recorded on 19th December 2024 (AEDT)

Join the next Wellnex Life webcast

FEATURED SPEAKERS

Zack Bozinovski

Managing Director

Zack is a highly successful and seasoned executive in the Australian retail industry with over 35 years’ experience within FMCG and Pharmaceutical companies in Australia and internationally. Zack has previously held senior positions at Uncle Tobys/Goodman Fielder, PepsiCo and Sigma and successfully developed and established many brands in the Australian retail sector. Zack most recently held the position of Managing Director at Brands Solutions Australia. Zack was also a co-founder of Voost Vitamins, recently sold to Proctor & Gamble.

George Tambassis

Non-Executive Chairman

Mr Tambassis is a pharmacist with over 35 years of operational experience in Community Pharmacies, and was a Non-Executive Director of ASX listed pharmaceutical wholesaler and franchisor Australian Pharmaceutical Industries (API), a Non-Executive Director at Kings Transport Consolidated Group Pty Ltd, and Chair of the Advisory Board at the Australian Biologics Academy – part of the Arrotex Pharmaceuticals group of companies.